Human Immunodeficiency Virus (HIV) Drugs Market Growth, Demand, SegmentPosted by vinit sawant on February 9th, 2021 The human immunodeficiency virus (HIV) spreads through body fluids, such as blood and seminal fluid, and attacks the human immune system, especially CD4 cells (often called T cells). The weakening of the immune system results in the occurrence of opportunistic infections and results in acquired immunodeficiency syndrome (AIDS). Market Forecast Human Immunodeficiency Virus (HIV) Drugs Market is expected to cross USD 33.7 Million by 2025 at a CAGR of 5% during the forecast period. Market Influencer Increasing awareness about HIV treatment, extensive research & development for new drugs, and a large number of patients diagnosed with HIV annually are impacting the market. Market Drivers
The number of individuals diagnosed with HIV has grown exponentially over the years. For instance, in 2018, the number of individuals infected by HIV worldwide was reportedly 1.7 million.
Due to the rising awareness of HIV infection and its treatment options, the number of individuals undergoing HIV treatment is increasing. For instance, in 2018, 23.3 million HIV patients were undergoing antiretroviral therapy (ART) globally. The number has increased by 1.6 million as compared to 2017 and 8 million as compared to 2010. Like it? Share it!More by this author |